Bronchitis - Asthma

Product NDC
55714-4407
11-digit product format
557144407
Labeler code
55714
Product ID
55714-4407_4e0446dd-eef0-bab4-8096-85d3b79f4263
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Influenza A Virus, Influenza B Virus, Antimon. tart., Arsenicum alb., Bryonia, Camphora, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Hepar sulph. calc., Histaminum hydrochloricum, Ipecac., Kali bic., Kali carb., Kali iod., Lycopodium, Myrrha, Natrum sulphuricum, Nux vom., Phosphorus, Pulsatilla, Sanguinaria, Spongia , Stannum met., Tussilago farfara, Verbascum, Echinacea, Lappa, Rumex crisp.
Dosage form
PELLET
Route
ORAL
Labeler
Newton Laboratories, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2011-06-01
Marketing end
0000-00-00
Substance
INFLUENZA A VIRUS; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA; EUCALYPTUS GLOBULUS LEAF; CALCIUM SULFIDE; HISTAMINE DIHYDROCHLORIDE; IPECAC; POTASSIUM DICHROMATE; POTASSIUM CARBONATE; POTASSIUM IODIDE; LYCOPODIUM CLAVATUM SPORE; MYRRH; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHORUS; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN; TUSSILAGO FARFARA; VERBASCUM THAPSUS; ECHINACEA, UNSPECIFIED; ARCTIUM LAPPA ROOT; RUMEX CRISPUS ROOT; INFLUENZA B VIRUS
Active strength
30 [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g
Pharmacologic classes
Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS],Seed Storage Proteins [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record